# Hormone Therapy in Treating Patients With Prostate Cancer

> **NCT00003323** · PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 101 (actual)

## Conditions studied

- Prostate Cancer
- Sexual Dysfunction and Infertility

## Interventions

- **DRUG:** finasteride
- **DRUG:** flutamide
- **OTHER:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00003323
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-05
- **Primary completion:** 2002-05
- **Final completion:** 2010-03
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2016-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003323, "Hormone Therapy in Treating Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00003323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*